Detalhe da pesquisa
1.
Targeting BTK in B Cell Malignancies: From Mode of Action to Resistance Mechanisms.
Int J Mol Sci
; 25(6)2024 Mar 12.
Artigo
Inglês
| MEDLINE | ID: mdl-38542207
2.
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.
Br J Haematol
; 203(3): 416-425, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37580908
3.
Treatment Refractoriness in Chronic Lymphocytic Leukemia: Old and New Molecular Biomarkers.
Int J Mol Sci
; 24(12)2023 Jun 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37373521
4.
Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
Br J Haematol
; 198(6): 1016-1022, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35829664
5.
New Frontiers in Monoclonal Antibodies for the Targeted Therapy of Acute Myeloid Leukemia and Myelodysplastic Syndromes.
Int J Mol Sci
; 23(14)2022 Jul 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35886899
6.
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Hematol Oncol
; 41(3): 567-570, 2023 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36190298
7.
Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy.
Cancers (Basel)
; 15(4)2023 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-36831361
8.
Richter Syndrome: From Molecular Pathogenesis to Druggable Targets.
Cancers (Basel)
; 14(19)2022 Sep 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36230566
9.
A STEP ahead for CAR-T cell therapy of large B cell lymphoma: understanding the molecular determinants of resistance.
Transl Cancer Res
; 12(11): 2970-2975, 2023 Nov 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38130313
10.
How a Medical Association Can Make a Difference in a Crisis Situation.
Hemasphere
; 6(9): e765, 2022 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-35966765